272BIO Limited is an animal health antibody discovery company. Our strategy is to discover and develop highly innovative, afforable antibody therapeutics to treat companion animals and livestock.
272BIO Limited is a R&D company with run by a team of experienced antibody drug discovery experts looking to transform the animal health medicines market.
Company Details
- Employees
- 19
- Founded
- -
- Address
- Innovation Centre, The Pirbright Institute,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://272bio.com
- HQ
- Pirbright, Surrey
272bio Limited Questions
272Bio Limited's website is http://272bio.com
272Bio Limited's LinkedIn profile is https://uk.linkedin.com/company/credos-biotherapeutics
272Bio Limited has
19 employees.
View email and phone details for 19
employees at 272Bio Limited.
272Bio Limited's industry is
Biotechnology Research
272Bio Limited's top competitors are
Xeos,
Act Blade,
17cicada,
Adc Therapeutics,
Acrobiosystems,
4bio Capital,
Molecubes,
3s Knowledge,
Ignota Labs,
Abcam.
272Bio Limited's categories are Biotechnology Research
272Bio Limited's founding year is 2019
